CNCR

ETF Series Solutions Trust Range Cancer Therapeutics ETF
CNCR

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

CNCR was delisted on the 27th of May, 2025.

Back to rankings

13 hedge funds and large institutions have $7.84M invested in ETF Series Solutions Trust Range Cancer Therapeutics ETF in 2017 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding: →

2.1% more ownership

Funds ownership: 15.46% → 17.56% (+2.1%)

Holders
13
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$478K
2
+$356K
3
+$287K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$239K
5
WAP
Wealthcare Advisory Partners
Pennsylvania
+$43K

Top Sellers

1
-$273K
2
-$16.1K
3
-$5.08K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$4.41M
2
$1.18M
3
$848K
4
$360K
5
$356K
6
$339K
7
$239K
8
$43K
9
$27K
10
$18K
11
$17K
12
$8K
13
$2K
14
–